ISPOR - PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil

Full Text

PRS26 Economic Evaluation of Omalizumab in Patients With Uncontrolled Severe Allergic Asthma From the Public Payer Perspective in Brazil

Abstract

Authors

C. Suzuki C. Pepe N.L. Silva

Back to Volume 15, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now